ClinicalTrials.Veeva

Menu

Specific Methylation Profiles in HNSCC

A

Aalborg University Hospital

Status

Enrolling

Conditions

Head and Neck Squamous Cell Carcinoma

Treatments

Diagnostic Test: Blood sample

Study type

Observational

Funder types

Other

Identifiers

NCT04567056
N-20190047-2

Details and patient eligibility

About

In the study, N-20190047, the investigators aim to define specific methylation patterns in a group of patients with head and neck squamous cell carcinomas.

With this study the investigators aim to validate these findings in a larger cohort.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Cancer group:

Inclusion Criteria:

  • Written informed consent
  • Verified head and neck squamous cell carcinoma

Exclusion Criteria:

  • Other active cancer
  • Uncontrolled comorbidity
  • Unable to give informed consent

Control group:

Inclusion Criteria:

  • Written informed consent
  • Normal ENT-examination

Exclusion Criteria:

  • Other active cancer
  • Uncontrolled comorbidity
  • Unable to give informed consent

Trial design

300 participants in 2 patient groups

Cancer group
Description:
Patients with verified head and neck squamous cell carcinomas
Treatment:
Diagnostic Test: Blood sample
Control group
Description:
Matched control group without active or earlier cancer and a normal ENT examination.
Treatment:
Diagnostic Test: Blood sample

Trial contacts and locations

1

Loading...

Central trial contact

Michael Gaihede, Professor; Christian Danstrup, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems